Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
종목 코드 RDY
회사 이름Dr Reddy's Laboratories Ltd
상장일Jan 01, 1986
CEOAghanian (Patrick)
직원 수27811
유형Depository Receipt
회계 연도 종료Jan 01
주소8-2-337, Road No.3 Banjara Hills
도시HYDERABAD
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가India
우편 번호500-034
전화914049002900
웹사이트https://www.drreddys.com/
종목 코드 RDY
상장일Jan 01, 1986
CEOAghanian (Patrick)